Canada Opens its Doors to Global Med Technologies(R), Inc. First Canadian Site has Implemented SafeTrace Tx(R) DENVER, April 5 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the first Canadian customer to go live on its SafeTrace Tx*(R) advanced transfusion management system. Canada is one of several international markets targeted for growth by Wyndgate. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Will Willman, Senior Vice President of International Business Development stated, "The Global Med and Canadian team worked well together in the implementation of this Canadian site and proved that our blood bank solutions are architected to operate efficiently in the international marketplace. This first Canadian customer will provide an excellent reference site and has the potential to accelerate our expansion into Canada." Mr. Willman added, "Under extreme pressure because its old blood bank system was being removed from the market, this client was extremely pleased that Wyndgate was able to meet its aggressive implementation timelines." Thomas F. Marcinek, President and COO of Global Med, stated, "The high quality of our products and the competency and dedication of our people provide the foundation for future installations in Canada and other international markets. These markets provide a previously untapped potential for Global Med, and we are excited about the prospect of expanding our international business." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in sub-Saharan Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe", "estimate", "project", "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R), Inc., +1-303-238-2000; or Investor Relations, John Nesbett, or Jordan Silverstein, both of The Investor Relations Group, +1-212-825-3210, both for Global Med Technologies Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/

Copyright